Anal Carcinoma Clinical Trial
Official title:
Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?
Anal canal cell carcinoma is a very rare cancer but well treated. If the morphological test
are well established in the initial evaluation, it's not the case of the follow up evaluation
particularly by MRI.About 1/3 of patient decline with metastatic relapse during the follow up
of these patients.It appears that clinical regression seen precociously is a predictive
factor of survival without relapse. But there 's no study confirming that point.
This context takes us to evaluate if there is a predictive factor in MRI to final clinical
result.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02408861 -
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
|
Phase 1 | |
| Recruiting |
NCT05663502 -
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
|
||
| Active, not recruiting |
NCT00867464 -
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
|
||
| Active, not recruiting |
NCT04272034 -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT05787535 -
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
|
Phase 1 | |
| Active, not recruiting |
NCT04505553 -
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT04230759 -
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group
|
Phase 2 | |
| Active, not recruiting |
NCT04713618 -
Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy
|
||
| Recruiting |
NCT05438836 -
Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
|
||
| Completed |
NCT00423254 -
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
|
Phase 1 | |
| Recruiting |
NCT02369939 -
Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy
|
Phase 3 | |
| Recruiting |
NCT02628067 -
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
|
Phase 2 | |
| Recruiting |
NCT01877135 -
Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients
|
N/A | |
| Recruiting |
NCT03241680 -
Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III)
|
N/A | |
| Active, not recruiting |
NCT02816879 -
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
|
N/A | |
| Recruiting |
NCT04802876 -
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors
|
Phase 2 |